New Delhi, April 13 (IANS) India is poised to lead the global pharmaceutical landscape due to its focus on biologics, biosimilars and specialty medicines, Health Minister JP Nadda said on Monday.The minister highlighted that the government recently launched Biopharma Shakti Initiative with an outlay of Rs 10,000 crore, to advance capabilities in biopharmaceutical innovation, foster innovation and strengthen research capabilities. Union Minister of State for Health and Family Welfare, Anupriya Pa…
Latest PRIP scheme News & Updates
New Delhi, March 21 (IANS) Union Minister Dr Jitendra Singh on Saturday said that India is steadily evolving into a robust pharma economy, which could help as a significant contributor to the country’s overall GDP.During his address at a ‘Healthcare Summit’ here, the minister stated the nation’s pharmaceutical, medtech and manufacturing ecosystem is positioning the country as a key global manufacturing hub — particularly in high-quality, affordable healthcare solutions.The minister said that …
New Delhi, Jan 6 (IANS) The Indian pharma industry in 2025 saw a major leap with the government’s flagship Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP), and schemes like the Production Linked Incentive (PLI) and Promotion of Research and Innovation in Pharma Medtech Sector (PRIP), the government said on Tuesday.In an official statement, the Ministry of Chemicals and Fertilisers stated that under the PMBJP, 2,202 Jan Aushadhi Kendras (JAKs) were opened in 2025, taking the total number…
New Delhi, Dec 25 (IANS)With GST reforms and Research Development Incentive (RDI) Scheme, the year 2025 has been a crucial turning point for Indian pharma, said industry experts on Thursday, while highlighting innovation and increased access as key factors for the sector’s growth in 2026.Indian pharma is standing at a defining moment. In the past 25 years, the industry has grown from $3 billion to $60 billion. The next 25 years will be shaped by innovation, quality, and access.“The year 2025…